Authors:
STROJAN P
BUDIHNA M
SMID L
VRHOVEC I
SKRK J
Citation: P. Strojan et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN TISSUE AND SERUM OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA PATIENTS, European journal of cancer, 34(8), 1998, pp. 1193-1197
Authors:
STROJAN P
BUDIHNA M
SMID L
VRHOVEC I
SKRK J
Citation: P. Strojan et al., CATHEPSIN-D IN TISSUE AND SERUM OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Cancer letters, 130(1-2), 1998, pp. 49-56
Citation: P. Strojan et Z. Rudolf, IMMUNOCHEMOTHERAPY WITH RECOMBINANT INTERFERON-ALPHA-2B PLUS DACARBAZINE IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA, Melanoma research, 7(5), 1997, pp. 420-427
Authors:
SMID L
STROJAN P
BUDIHNA M
SKRK J
VRHOVEC I
ZARGI M
KOS J
Citation: L. Smid et al., PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-D AND STEFIN-A AND STEFIN-B IN LARYNGEAL CARCINOMA, European archives of oto-rhino-laryngology, 254, 1997, pp. 150-153
Citation: P. Strojan et al., SUPERIOR SULCUS TUMOR (SST) - MANAGEMENT AT THE INSTITUTE-OF-ONCOLOGYIN LJUBLJANA, SLOVENIA, 1981-1994, Lung cancer, 17(2-3), 1997, pp. 249-259
Citation: P. Strojan et al., COMBINED RADIATION AND CHEMOTHERAPY FOR ADVANCED UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA IN CHILDREN, Medical and pediatric oncology, 28(5), 1997, pp. 366-369
Authors:
BUDIHNA M
STROJAN P
SMID L
SKRK J
VRHOVEC I
ZUPEVC A
RUDOLF Z
ZARGI M
KRASOVEC M
SVETIC B
KOPITARJERALA N
KOS J
Citation: M. Budihna et al., PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-H, CATHEPSIN-L, CATHEPSIN-D AND THEIR ENDOGENOUS INHIBITORS STEFIN-A AND STEFIN-B IN HEAD-AND-NECK-CARCINOMA, Biological chemistry Hoppe-Seyler, 377(6), 1996, pp. 385-390
Citation: Z. Rudolf et P. Strojan, DTIC VS IFN-ALPHA PINS DTIC IN THE TREATMENT OF PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, Neoplasma, 43(2), 1996, pp. 93-97